RCAS1 is associated with ductal breast cancer progression

Biochemical and Biophysical Research Communications

Volumn 293, Issue 5, 2002, Pages 1544-1549

  Rousseau, Joel ^a   Têtu, Bernard ^b   Caron, Danielle ^a   Malenfant, Patrick ^a   Cattaruzzi, Paola ^a   Audette, Marie ^a   Doillon, Charles ^a   Tremblay, Jacques P ^a   Guérette, Benoit ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Ductal breast cancer; EBAG9; Estrogen receptor; Immune escape; Immunohistochemistry; RCAS1

Indexed keywords

PROTEIN; PROTEIN RCAS1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER IMMUNOLOGY; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR BIOPSY;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL NUCLEUS; CYTOSOL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN BINDING; RECEPTORS, ESTROGEN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0036073582     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00401-1     Document Type: Article

References (32)

1. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas
2. Isolation of estrogen-responsive genes with a CpG island library
3. Promoter analysis and chromosomal mapping of human EBAG9 gene
4. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1
5. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1
6. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias
7. Estrogen receptor determination in fine needle aspirates of the breast. Correlation with histologic grade and comparison with biochemical analysis
8. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long term follow-up
9. A rapid assay for binding estradiol to uterine receptor(s)
10. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement
11. Phenotyping of immune cell infiltrates in breast and colorectal tumours
12. Flow cytometric analysis of tumours infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients
13. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas
14. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer
15. Phenotype analysis of tumor-infiltrating lymphocytes from human breast cancer
16. Phenotyping of human tumor-infiltrating lymphocytes before and after exposure to different in vitro stimulation conditions
17. The Fas-Fas-ligand system: A mechanism for immune evasion in human breast carcinomas
18. CD95 ligand expression as a mechanism of immune escape in breast cancer
19. HLA class1 antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions
20. High frequency of altered HLA class I phenotypes in invasives breast carcinomas
21. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma
22. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer
23. Selective localization of matrix metalloproteinase 9, b1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells
24. Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killers cells
25. High incidence of interleukin10 mRNA but not interleukin 2 mRNA detected in human breast tumours
26. Deacetylase activity of human tumor cells producing immunosupressive aminosugars: Its possible role in resistance to cell-mediated cytotoxicity
27. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells
28. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma
29. Expression of tumor-associated antigen RCAS1 in hepatocellular carcinoma
30. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: Expression and regulation by estrogen
31. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer
32. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium